Cargando…

Off-Label Use of Botulinum Toxin in Dermatology—Current State of the Art

Botulinum toxin (BoNT) is a neurotoxin produced by the Clostridium botulinum bacteria. Among seven different isoforms, only BoNT-A and BoNT-B are commercially used. Currently, botulinum toxin has been indicated by the U.S. Food and Drug Administration in several disorders, among others: chronic migr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lewandowski, Miłosz, Świerczewska, Zuzanna, Barańska-Rybak, Wioletta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147387/ https://www.ncbi.nlm.nih.gov/pubmed/35630620 http://dx.doi.org/10.3390/molecules27103143

Ejemplares similares

Could a handbook serve as a useful educational intervention in improving disease knowledge? A cross-sectional study among patients with hidradenitis suppurativa in Poland
por: Lewandowski, Miłosz, et al.
Publicado: (2022)

Immunomodulatory Drugs in the Treatment of Hidradenitis Suppurativa—Possibilities and Limitations
por: Świerczewska, Zuzanna, et al.
Publicado: (2022)

Microbiome in Hidradenitis Suppurativa—What We Know and Where We Are Heading
por: Świerczewska, Zuzanna, et al.
Publicado: (2022)

Are YouTube videos a reliable source of information about body dysmorphic disorder?
por: Dobosz, Maria, et al.
Publicado: (2023)

Antibiotic-Related Adverse Drug Reactions in Patients Treated on the Dermatology Ward of Medical University of Gdańsk
por: Sokolewicz, Ewa Maria, et al.
Publicado: (2021)

New trends in botulinum toxin use in dermatology
por: Guida, Stefania, et al.
Publicado: (2018)

Utilities of Botulinum Toxins in Dermatology and Cosmetology
por: Naik, Piyu Parth
Publicado: (2021)

Squamous Cell Carcinoma as a Complication of Long-Term Hydroxyurea Treatment
por: Lewandowski, Miłosz, et al.
Publicado: (2021)

Botulinum Toxin in the Field of Dermatology: Novel Indications
por: Kim, Yoon Seob, et al.
Publicado: (2017)

Off-Label Uses of Rituximab in Dermatology
por: Cole, Connor, et al.
Publicado: (2022)

Off Label Use of Botulinum Toxin in Children under Two Years of Age: A Systematic Review
por: Druschel, Claudia, et al.
Publicado: (2013)

Atopic dermatitis: current treatment guidelines. Statement of the experts of the Dermatological Section, Polish Society of Allergology, and the Allergology Section, Polish Society of Dermatology
por: Nowicki, Roman, et al.
Publicado: (2015)

Biologics in Dermatology: Off-Label Indications
por: Mitra, Debdeep, et al.
Publicado: (2020)

Off-label use of rituximab in dermatology: pemphigus treatment
por: Bomm, Lislaine, et al.
Publicado: (2013)

Potency of botulinum toxin drugs: test systems and labelling
por: Dressler, Dirk, et al.
Publicado: (2022)

BOTULINUM TOXIN
por: Nigam, P K, et al.
Publicado: (2010)

Botulinum toxin in cancer therapy—current perspectives and limitations
por: Grenda, Tomasz, et al.
Publicado: (2021)

Nanomaterials as a Successor of Antibiotics in Antibiotic-Resistant, Biofilm Infected Wounds?
por: Nowak, Marcela, et al.
Publicado: (2021)

Dataset of botulinum toxin A influence on interleukins under neuropathy
por: Zychowska, Magdalena, et al.
Publicado: (2016)

Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review
por: Martina, Emanuela, et al.
Publicado: (2021)

Electrical Stimulation of Injected Muscles to Boost Botulinum Toxin Effect on Spasticity: Rationale, Systematic Review and State of the Art
por: Picelli, Alessandro, et al.
Publicado: (2021)

A cry for help, do not omit the signs. Dermatitis artefacta – psychiatric problems in dermatological diseases (a review of 5 cases)
por: Wojewoda, Karolina, et al.
Publicado: (2012)

New indications for topical ivermectin 1% cream: a case series study
por: Barańska-Rybak, Wioletta, et al.
Publicado: (2019)

Headache and botulinum toxin
por: Porta, M., et al.
Publicado: (2005)

Immunogenicity of botulinum toxins
por: Naumann, Markus, et al.
Publicado: (2012)

Diffusion of Botulinum Toxins
por: Brodsky, Matthew A., et al.
Publicado: (2012)

Immunogenicity of botulinum toxin
por: Wee, Syeo Young, et al.
Publicado: (2022)

Therapeutic Use of Botulinum Toxin in Neurorehabilitation
por: Intiso, Domenico
Publicado: (2012)

Use of botulinum toxin in musculoskeletal pain
por: Singh, Jasvinder A
Publicado: (2013)

Use of botulinum toxin in Frey's syndrome
por: Freni, Francesco, et al.
Publicado: (2019)

Use of botulinum toxin for movement disorders
por: Camargo, Carlos Henrique Ferreira, et al.
Publicado: (2019)

Use of botulinum toxin for voiding dysfunction
por: Eldred-Evans, David, et al.
Publicado: (2017)

Multidisciplinary Treatment in Toxic Epidermal Necrolysis
por: Surowiecka, Agnieszka, et al.
Publicado: (2023)

Toxin yet not toxic: Botulinum toxin in dentistry
por: Archana, M.S.
Publicado: (2016)

Effectiveness and Safety of Botulinum Toxin Type A in Children with Musculoskeletal Conditions: What Is the Current State of Evidence?
por: Dahan-Oliel, Noémi, et al.
Publicado: (2012)

Alternative Methods for Testing Botulinum Toxin: Current Status and Future Perspectives
por: Nepal, Mahesh Raj, et al.
Publicado: (2020)

Use of botulinum toxin in aesthetic medicine and gynaecology: current approaches, controversies, and future directions
por: Etrusco, Andrea, et al.
Publicado: (2023)

Controversy: Botulinum Toxin in Pregnancy
por: Paul, Munish
Publicado: (2009)

Botulinum toxin: The Midas touch
por: Shilpa, P. S., et al.
Publicado: (2014)

Wound Modulation with Botulinum Toxin
por: Malik, Archana, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7vjd0hqgslrnna7a3lvhf4gh6s